Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · 2017 · 46 citations · 53 references
MedicineNeurologyNeuroscienceClinical NeuroscienceDementiaNeuropsychiatryCerebrospinal Fluid BiomarkersDementia BiomarkersDementia DiagnosisFrontotemporal DementiaNeurodegenerative DiseasesNeurodegenerative DisordersCerebrospinal Fluid Neurodegeneration MarkersCerebrospinal Fluid TauCsf-to-blood Biomarker RatiosDifferential Diagnosis CriteriaFrontotemporal Dementia DiagnosisNeuropsychological Test BatteriesTau Protein BiomarkersTotal Tau Protein
Abstract Introduction To prospectively determine the diagnostic value of cerebrospinal fluid (CSF) levels total‐tau (tau) to amyloid‐β 1–42 ratio (Aβ 1–42 ) ratio (tau/Aβ 1–42 ratio), phosphorylated‐tau (p‐tau) to tau ratio (p‐tau/tau ratio), neurofilament light chain (NfL) and YKL40 in the late‐onset frontal lobe syndrome, in particular for the differential diagnosis of behavioral variant frontotemporal dementia (bvFTD) versus primary psychiatric disorders (PSY). Method We included patients with a multidisciplinary 2‐year‐follow‐up diagnosis of probable/definite bvFTD ( n = 22) or PSY ( n = 25), who underwent a detailed neuropsychiatric clinical examination, neuropsychological test battery, and magnetic resonance imaging at baseline. In all cases, CSF was collected through lumbar puncture at baseline. We compared CSF biomarker levels between the two groups and measured the diagnostic accuracy for probable/definite bvFTD, using the follow‐up diagnosis as the reference standard. Results The best discriminators between probable/definite bvFTD and PSY were the levels of CSF NfL (area under the curve [AUC] 0.93, P < .001, 95% confidence interval [CI] 0.85–1.00), p‐tau/tau ratio (AUC 0.87, P < .001, 95% CI 0.77–0.97), and YKL40 (AUC 0.82, P = .001, 95% CI 0.68–0.97). The combination of these three biomarkers had a sensitivity of 91% (95% CI 66%–100%) at a specificity of 83% (95% CI 65%–95%) with an AUC of 0.94 ( P < .001, 95% CI 0.87–1.00) for bvFTD. CSF tau/Aβ 1–42 ratio was less accurate in differentiating between bvFTD and PSY. Discussion We found a good diagnostic accuracy for higher levels of CSF NfL and YKL40 and reduced p‐tau/tau ratio in distinguishing bvFTD from PSY. We advocate the use of these CSF biomarkers as potential additional tools to neuroimaging in the diagnosis of bvFTD versus PSY.
53
Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 86.9K citations
Older Adults' Reasons for Using Technology while Aging in Place
Sebastiaan Theodorus Michaël Peek, Katrien Luijkx, M. D. Rijnaard et al. · Gerontology · 2015 · 19.7K citations · Full text